Drug intelligence / Profile preview

mesenchymal stromal cells

Development stage
Unknown
Lead developer
Guangdong Provincial People's Hospital
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Mesenchymal stromal cells (MSCs) are a type of multipotent cell therapy being evaluated by the Guangdong Provincial People's Hospital for the treatment of chronic graft-versus-host disease (cGvHD). MSCs possess unique immunomodulatory properties, allowing them to migrate to sites of inflammation and suppress the activity of various immune cells, including T-cells, B-cells, and natural killer cells, which are responsible for the pathogenesis of cGvHD. In clinical trials, these cells are typically administered intravenously as an adjunct to standard immunosuppressive regimens, such as corticosteroids and calcineurin inhibitors, to improve response rates and reduce the severity of the disease in newly diagnosed or steroid-refractory patients. This specific MSC product is currently being evaluated in a Phase III randomized, open-label, multi-center study in Southern China.

Other names
mesenchymal stem cellsMSC

Beyond the preview

Go deeper on mesenchymal stromal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mesenchymal stromal cells.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call